Jane Street Group, LLC Repligen Corp Put Options Transaction History

Jane Street Group, LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$119.79 - $167.35 $6.1 Million - $8.52 Million	50,900 New	50,900 $7.57 Million
Q1 2022 May 17, 2022	SELL	$161.19 - $257.96 $80,595 - $128,979	-500 Reduced 1.53%	32,200 $6.06 Million
Q4 2021 Feb 15, 2022	SELL	$247.59 - $304.47 $5.03 Million - $6.18 Million	-20,300 Reduced 38.3%	32,700 $8.66 Million
Q3 2021 Nov 16, 2021	BUY	$194.77 - $324.21 $7.79 Million - $13 Million	40,000 Added 307.69%	53,000 $15.3 Million
Q2 2021 Aug 16, 2021	SELL	$165.87 - $220.95 $3.27 Million - $4.35 Million	-19,700 Reduced 60.24%	13,000 $2.6 Million
Q1 2021 May 18, 2021	BUY	$180.37 - $226.26 $3.17 Million - $3.98 Million	17,600 Added 116.56%	32,700 $6.36 Million
Q4 2020 Feb 17, 2021	BUY	$148.08 - $206.57 $1.95 Million - $2.73 Million	13,200 Added 694.74%	15,100 $2.89 Million
Q3 2020 Nov 17, 2020	SELL	$122.51 - $158.27 $330,777 - $427,329	-2,700 Reduced 58.7%	1,900 $280,000
Q2 2020 Aug 17, 2020	BUY	$94.33 - $140.48 $433,918 - $646,208	4,600 New	4,600 $569,000

479

54.5M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $9.22B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.